glp-1 receptor agonist brands Agonists GLP-1 Receptor Agonists Linked to

Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, and Alba LM

Basic & clinical pharmacology & toxicology

We need a large prospective study to determine whether use of these GLP-1 drugs can help many women avoid developing the disease at all

Reduced inflammation may be one of the reasons, including weight loss and better blood sugar control, why

Although activation of the GLP-1 receptor primarily facilitates weight reduction through appetite suppression, the inclusion of GIP receptor agonism offers supplementary and synergistic advantages, including improved insulin sensitivity and overall metabolic health

Conclusion GLP-1 therapies have shown promise in improving heart health and supporting weight loss, with major trials highlighting their ability to reduce key cardiovascular events across a variety of patient groups